SQI Diagnostics Inc.
SQDH.V
TSX
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -51.58% | 908.89% | 773.43% | 591.44% | 522.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.58% | 908.89% | 773.43% | 591.44% | 522.01% |
| Cost of Revenue | 12.50% | 3,899.41% | 3,183.03% | 1,719.74% | 1,023.08% |
| Gross Profit | -103.53% | 351.94% | 302.90% | 330.33% | 356.80% |
| SG&A Expenses | 15.43% | 101.23% | 106.18% | 79.72% | -32.53% |
| Depreciation & Amortization | 2,728.86% | 2,728.86% | 4,012.23% | 3,636.40% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.95% | 93.28% | 93.54% | 69.66% | 22.99% |
| Operating Income | -41.23% | -27.06% | -32.82% | -18.58% | 21.32% |
| Income Before Tax | -97.31% | -71.58% | -74.19% | -25.44% | 16.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -97.31% | -71.58% | -74.19% | -25.44% | 16.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.31% | -71.58% | -74.19% | -25.44% | 16.73% |
| EBIT | -41.23% | -27.06% | -32.82% | -18.58% | 21.32% |
| EBITDA | -16.61% | 2.74% | -3.78% | -3.58% | 26.02% |
| EPS Basic | -87.24% | -55.26% | -48.79% | -5.00% | 30.74% |
| Normalized Basic EPS | -63.20% | -38.00% | -27.61% | -1.78% | 31.69% |
| EPS Diluted | -87.24% | -55.26% | -48.79% | -5.00% | 30.74% |
| Normalized Diluted EPS | -63.20% | -38.00% | -27.61% | -1.78% | 31.69% |
| Average Basic Shares Outstanding | 7.43% | 10.65% | 15.13% | 17.73% | 20.54% |
| Average Diluted Shares Outstanding | 7.43% | 10.65% | 15.13% | 17.73% | 20.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
